Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...
Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing ...
CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Gearing Up for Phase 3 Trial of Tecarfarin Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) is a biopharmaceutical company developing tecarfarin, a ...
News Medical on MSN19h
Heart failure patients benefit from dapagliflozin after TAVR procedurePatients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve ...
6-month-old Struthers' baby Ariella Torres received her third open heart surgery Monday in Cincinnati. The parents of Ariella ...
In the rarest of rare cases and a groundbreaking medical achievement, Medica Superspecialty Hospital in Kolkata achieved a momentous feat by successfully implanting a Micra leadless pacemaker in a ...
MedPage Today on MSN2d
SGLT2i Improves Outcomes After TAVIAs heart failure patients, the TAVI population studied already is recommended to be treated with an SGLT2 inhibitor, noted ...
Background Cardiac surgery carries a heightened risk of bradyarrhythmias, but current permanent pacemaker (PPM) implantation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback